磯野誠

Isono Makoto

所属機関・部署：
職名：院長

研究分野 (1件)：泌尿器科学

競争的資金等の研究課題 (2件)：

論文 (41件)：

Shuhei Yamada, Haruka Miyata, Makoto Isono, Kanta Hori, Junko Yanagawa, Aiko Murai, Tomoyuki Minowa, Yuka Mizue, Kenta Sasaki, Kenji Murata, et al. Cisplatin resistance driver claspin is a target for immunotherapy in urothelial carcinoma. Cancer immunology, immunotherapy : CII. 2023. 72. 7. 2057-2065
Makoto Isono, Kazuki Okubo, Takako Asano, Akinori Sato. Ataxia telangiectasia and Rad3-related inhibition by AZD6738 enhances gemcitabine-induced cytotoxic effects in bladder cancer cells. PloS one. 2022. 17. 4. e0266476
Kazuki Okubo, Makoto Isono, Takako Asano, Nina REßING, Wolfgang A Schulz, Finn K Hansen, Akinori Sato. Ubiquitin-proteasome System Is a Promising Target for Killing Cisplatin-resistant Bladder Cancer Cells. Anticancer research. 2021. 41. 6. 2901-2912
Makoto Isono, Kazuki Okubo, Takako Asano, Akinori Sato. Inhibition of checkpoint kinase 1 potentiates anticancer activity of gemcitabine in bladder cancer cells. Scientific reports. 2021. 11. 1. 10181-10181
Kazuki Okubo, Fumiko Hamabe, Kosuke Miyai, Makoto Isono, Hiroshi Shinmoto, Akinori Sato. Prostate cancer recurrence mimicking invasive urothelial cancer of the bladder. Urology case reports. 2020. 33. 101421-101421

MISC (18件)：

升永綾子, 伊藤敬一, 川口真, 新地祐介, 磯野誠, 田崎新資, 黒田健司, 佐藤全伯, 朝隈純一, 堀口明男, et al. 進行性腎癌に対するアキシチニブの治療成績. 泌尿器外科. 2018. 31. 臨増. 856-856
Asano Takako, Sato Akinori, Okubo Kazuki, Isono Makoto, Asano Tomohiko. RITONAVIR AND IXAZOMIB INHIBIT RENAL CANCER GROWTH IN VITRO AND IN VIVO BY INDUCING ENDOPLASMIC RETICULUM STRESS SYNERGISTICALLY. JOURNAL OF UROLOGY. 2018. 199. 4. E955
Isono Makoto, Sato Akinori, Asano Takako, Okubo Kazuki, Asano Tomohiko. Sensitization of Urothelial Carcinoma Cells to Gemcitabine by the Checkpoint Kinase Inhibitor MK-8776. CANCER SCIENCE. 2018. 109. 305
Sato Akinori, Asano Takako, Isono Makoto, Okubo Kazuki, Asano Tomohiko. Inducing endoplasmic reticulum stress to kill urological cancer cells. CANCER SCIENCE. 2018. 109. 356
Asano Takako, Sato Akinori, Okubo Kazuki, Isono Makoto, Asano Tomohiko. Ritonavir interacts with ixazomib to inhibit renal cancer growth synergistically. CANCER SCIENCE. 2018. 109. 332

講演・口頭発表等 (95件)：

The ataxia telangiectasia and Rad3-related kinase inhibitor AZD6738 overcomes cisplatin resistance in long-term cisplatin treated bladder cancer cells.
(The 34th Annual Congress of European Association of Urology 2019)
進行性腎癌に対するアキシチニブの治療成績
(泌尿器外科 2018)
The ataxia telangiectasia and Rad3-related kinase inhibitor AZD6738 sensitizes bladder cancer cells to gemcitabine.
(The 33rd Annual Congress of European Association of Urology 2018)
急速な転機を辿った腎粘液管状紡錘細胞癌の1例
(日本泌尿器科学会東部総会プログラム・抄録集 2018)
Inducing endoplasmic reticulum stress to kill urological cancer cells
(CANCER SCIENCE 2018)

学位 (1件)：

経歴 (11件)：

全件表示

所属学会 (5件)：

日本生殖医学会 , 日本透析医学会 , 日本癌学会 , 日本泌尿器内視鏡学会 , 日本泌尿器科学会

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

磯野 誠